|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Nevada Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing NevadaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
PDL BioPharma, Inc.
| | | Phone: | (775) 832-8500 | Fax: | (775) 832-8501 | Year Established: | 1986 | Ticker: | PDLI | Exchange: | NASDAQ | Main Contact: | John McLaughlin, CEO | | Other Contacts: | Dominique P. Monnet, President Jill M. Jene, Ph.D., VP, Business Development Peter Garcia, VP, CFO Nathan Kryszak, Associate General Counsel Christopher L. Stone, VP & General Counsel
| | Company Description | PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed by leading pharmaceutical and biotechnology companies today based on patents which expire in late 2014. | |
|
|
|
|
|